Monopar Therapeutics Inc. 13D and 13G filings for Monopar Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 5:01 pm Purchase | 2024-12-09 | 13D | Monopar Therapeutics Inc. MNPR | Monopar Therapeutics MNPR | 704,829 13.400% | 704,829 (New Position) | Filing |